Edwards Lifesciences Corp

EWNYSEUSD
91.79 USD
0.42 (0.46%)AT CLOSE (11:59 AM EDT)
90.88
0.91 (0.99%)
POST MARKET (AS OF 07:35 PM EDT)
Post Market
AS OF 07:35 PM EDT
90.88
0.91 (0.99%)
🔴Market: CLOSED

Edwards Lifesciences Corp (EW) trades at $90.75 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jul 13, 2026.

Open?$92.28
High?$93.09
Low?$91.50
Prev. Close?$92.21
Volume?3.3M
Avg. Volume?5.0M
VWAP?$92.07
Rel. Volume?0.65x
Bid / Ask
Bid?$87.00 × 100
Ask?$91.75 × 300
Spread?$4.75
Midpoint?$89.38
Valuation & Ratios
Market Cap?53.1B
Shares Out?575.8M
Float?571.0M
Float %?99.2%
P/E Ratio?48.44
P/B Ratio?5.14
EPS?$1.90
Dividend?0.00%
Ex-Dividend?N/A
RelatedAMNHSIC
News
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Employees
16.0K
Market Cap
53.1B
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Listed
2000-04-03
Address
ONE EDWARDS WAY
IRVINE, CA 92614
Phone: (949) 250-2500
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
20
Short Sent.?
84
Piotroski F-Score?3/9Weak
Altman Z-Score?13.41Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.01%Low
Short Interest?11.5M
Days to Cover?2.1
Free Float571.0M
Avg Daily Volume5.4M
Settlement Date2026-06-30
Financial Health
Current Ratio?4.42Strong
Quick Ratio?3.63Strong
Cash Ratio?1.74Strong
Debt/Equity?0.06Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
39/100
P/E?
Peers
50
S&P
13
48.4PRICEY
P/B?
Peers
33
S&P
36
5.14FAIR
P/S?
Peers
33
S&P
11
8.42HIGH
P/FCF?
Peers
33
S&P
10
48.7PRICEY
EV/EBITDA?
Peers
33
S&P
13
27.5HIGH
EV/Sales?
Peers
33
S&P
16
8.13HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
37
10.6%FAIR
ROA?
Peers
100
S&P
67
8.2%STRONG
Cash Flow & Enterprise
FCF?$1.1B
Enterprise Value?$51.2B
Fundamentals ratios updated end of day